SunWay Biotech Co., Ltd.(TW:1271)
NT$58.80+0.80 (+1.38%)
TW:1271
SunWay Biotech Co., Ltd. financials statements
NT$58.80
At close:+0.80 (+1.38%)
SunWay Biotech Co., Ltd. (1271) Financial Statements
SunWay Biotech Co., Ltd. Financial Overview
SunWay Biotech Co., Ltd.'s market cap is currently NT$4.53B. The company's EPS TTM is NT$2.19; its P/E ratio is 26.85; and it has a dividend yield of 1.33%. SunWay Biotech Co., Ltd. has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | NT$ 993.30M | NT$ 970.18M | NT$ 571.11M | NT$ 425.35M | NT$ 380.43M |
| Gross Profit | NT$ 560.50M | NT$ 545.04M | NT$ 236.91M | NT$ 149.89M | NT$ 271.11M |
| Operating Income | NT$ 104.13M | NT$ 140.98M | NT$ 52.44M | NT$ 39.23M | NT$ 167.74M |
| EBITDA | NT$ 197.44M | NT$ 231.26M | NT$ 83.22M | NT$ 48.54M | NT$ 190.47M |
| Net Income | NT$ 101.49M | NT$ 118.57M | NT$ 46.09M | NT$ 30.04M | NT$ 168.76M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | NT$ 301.02M | NT$ 293.70M | NT$ 362.19M | NT$ 123.57M | NT$ 346.44M |
| Total Assets | NT$ 4.46B | NT$ 3.79B | NT$ 3.66B | NT$ 478.23M | NT$ 607.70M |
| Total Debt | NT$ 886.45M | NT$ 249.85M | NT$ 303.55M | NT$ 71.34M | NT$ 20.69M |
| Net Debt | NT$ 585.42M | NT$ -43.85M | NT$ -58.64M | NT$ -52.23M | NT$ -325.75M |
| Total Liabilities | NT$ 1.20B | NT$ 527.13M | NT$ 455.11M | NT$ 190.14M | NT$ 60.65M |
| Stockholders' Equity | NT$ 3.26B | NT$ 3.26B | NT$ 3.20B | NT$ 288.09M | NT$ 543.66M |
| Cash Flow | |||||
| Free Cash Flow | NT$ 118.87M | NT$ 33.24M | NT$ 9.75M | NT$ 39.99M | NT$ 150.96M |
| Operating Cash Flow | NT$ 222.89M | NT$ 156.92M | NT$ 55.98M | NT$ 42.58M | NT$ 160.76M |
| Investing Cash Flow | NT$ -754.59M | NT$ -125.80M | NT$ 218.78M | NT$ -3.48M | NT$ -10.86M |
| Financing Cash Flow | NT$ 539.13M | NT$ -99.80M | NT$ -35.46M | NT$ -5.33M | NT$ -98.40M |
Currency in TWD
